All In Biotech

Drug Trial Radar · NCT02163499

Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months

Multicenter, Multi-Dose, Open-Label Maintenance of Long-Term Safety and Efficacy of Sodium Zirconium Cyclosilicate (ZS) in Hyperkalemia

Last checked: Nov 20, 2026Latest source record: Jun 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

751

Actual

Start

Jun 30, 2014

Primary completion

Nov 30, 2016

Study completion Nov 30, 2016

Sponsor

Lead sponsor
ZS Pharma, Inc.Industry
Sponsor type
Industry
First posted
Jun 13, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Supportive care
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Open-Label Maintenance Study contains an Acute Phase, in which subjects will be dosed with ZS 10 g three times daily (tid) for 24 to 72 hours, followed by a long-term Maintenance Phase.

Conditions

  • Hyperkalemia

Interventions

  • Sodium Zirconium CyclosilicateDrug

    Acute Phase Dosing: Sodium Zirconium Cyclosilicate 10 g three times daily (TID) for 24 to 72 Extended Dosing: Sodium Zirconium Cyclosilicate 5 g once daily (QD). Sodium Zirconium Cyclosilicate dose increased or decreased in increments/decrements of 5 g QD up to a maximum of 15 g QD or a minimum of 5 g every other day (QOD) based on i-STAT potassium measurements up to 12 months.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent of Participants With Restoration of Normal Serum Potassium (S-K) Values (3.5 to 5.0 mmol/L, Inclusive) at the End of the Acute PhaseTime frame: 72 Hours
  2. Percentage of Participants With Mean S-K Values ≤ 5.1 mmol/L During Extended Dosing Phase Days 85 to 365Time frame: Study Days 85 to 365

Locations

50 sites in 7 countries. Site status is shown where the registry gives one.

  • Site not named

    Scottsboro, Alabama

  • Site not named

    Tempe, Arizona

  • Site not named

    Tucson, Arizona

  • Site not named

    Chula Vista, California

  • Site not named

    Los Angeles, California

  • Site not named

    Paramount, California

  • Site not named

    Riverside, California

  • Site not named

    Sacramento, California

  • Site not named

    Whittier, California

  • Site not named

    Denver, Colorado

  • Site not named

    Brandon, Florida

  • Site not named

    DeLand, Florida

  • Site not named

    Hudson, Florida

  • Site not named

    Lauderdale Lakes, Florida

  • Site not named

    Miami, Florida

  • Site not named

    Miami, Florida

  • Site not named

    Miami Lakes, Florida

  • Site not named

    New Smyrna Beach, Florida

  • Site not named

    Tampa, Florida

  • Site not named

    Winter Park, Florida

  • Site not named

    Columbus, Georgia

  • Site not named

    Evergreen Park, Illinois

  • Site not named

    Joliet, Illinois

  • Site not named

    Paducah, Kentucky

  • Site not named

    Shreveport, Louisiana

  • Site not named

    Chesterfield, Michigan

  • Site not named

    Kansas City, Missouri

  • Site not named

    St Louis, Missouri

  • Site not named

    Great Neck, New York

  • Site not named

    Providence, Rhode Island

  • Site not named

    Orangeburg, South Carolina

  • Site not named

    Sumter, South Carolina

  • Site not named

    Chattanooga, Tennessee

  • Site not named

    San Antonio, Texas

  • Site not named

    San Antonio, Texas

  • Site not named

    St. George, Utah

  • Site not named

    Gosford, New South Wales, Australia

  • Site not named

    Woolloongabba, Queensland, Australia

  • Site not named

    Heidelberg, Victoria, Australia

  • Site not named

    Melbourne, Victoria, Australia

Showing 40 of 50 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.